SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014559
Filing Date
2024-04-15
Accepted
2024-04-15 09:00:13
Documents
19
Period of Report
2024-04-15
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50301
2 ex10-1.htm EX-10.1 141784
3 ex10-2.htm EX-10.2 97267
4 ex10-3.htm EX-10.3 97854
5 ex10-4.htm EX-10.4 88086
6 ex10-5.htm EX-10.5 111969
7 ex99-1.htm EX-99.1 18795
  Complete submission text file 0001493152-24-014559.txt   893455

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE rnxt-20240415.xsd EX-101.SCH 3015
9 XBRL LABEL FILE rnxt-20240415_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE rnxt-20240415_pre.xml EX-101.PRE 22359
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3396
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 24843247
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)